Pfizer (PFE) Prepaid Assets (2016 - 2025)
Historic Prepaid Assets for Pfizer (PFE) over the last 15 years, with Q3 2025 value amounting to $2.4 billion.
- Pfizer's Prepaid Assets fell 3883.27% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 3883.27%. This contributed to the annual value of $4.3 billion for FY2024, which is 1339.85% down from last year.
- According to the latest figures from Q3 2025, Pfizer's Prepaid Assets is $2.4 billion, which was down 3883.27% from $2.7 billion recorded in Q2 2025.
- Pfizer's Prepaid Assets' 5-year high stood at $6.1 billion during Q4 2022, with a 5-year trough of $2.4 billion in Q3 2025.
- For the 5-year period, Pfizer's Prepaid Assets averaged around $4.3 billion, with its median value being $4.2 billion (2022).
- Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 6224.27% in 2022, then tumbled by 3883.27% in 2025.
- Quarter analysis of 5 years shows Pfizer's Prepaid Assets stood at $3.8 billion in 2021, then surged by 31.34% to $5.0 billion in 2022, then fell by 2.11% to $4.9 billion in 2023, then dropped by 13.4% to $4.3 billion in 2024, then crashed by 44.56% to $2.4 billion in 2025.
- Its Prepaid Assets stands at $2.4 billion for Q3 2025, versus $2.7 billion for Q2 2025 and $2.9 billion for Q1 2025.